97278 ⎘
Immunoglobulins specific features characterized by immunoglobulin fragments; Constant or Fc region; Isotype CH4 domain
CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN AND ENCODING POLYNUCLEOTIDES
#2TARGETING EPHA3 AND USES THEREOF
#3NOVEL METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX
#4METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX
#5MULTISPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
#6HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
#7BISPECIFIC ANTIBODY
#8MULTIFUNCTIONAL BISPECIFIC FUSION POLYPEPTIDE
#9ANTIGEN-BINDING PROTEIN COMPRISING TWO FC DOMAINS AND USE THEREOF
#10MULTIVALENT LINKERS USED FOR ANTIBODY LABELING
#11HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
#12MYELOPROLIFERATIVE CONDITIONS
#13Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs
#14CHIMERIC IMMUNOGLOBULIN
#15HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
#16BISPECIFIC ANTIBODY
#17METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX
#18Bispecific antibody
#19NOVEL HETERODIMERIC PROTEINS
#20Methods of treating neutorpenia using G-CSF protein complex
#21POLYPEPTIDE VARIANTS AND USES THEREOF
#22PROTEIN COMPLEX BY USE OF A SPECIFIC SITE OF AN IMMUNOGLOBULIN FRAGMENT FOR LINKAGE
#23Heterodimeric antibodies that bind CD3 and tumor antigens
#24Anti-MET antibodies and uses thereof
#25C-terminal lysine conjugated immunoglobulins
#26ANTIBODY CONSTANT REGION VARIANT
#27Heterodimeric antibodies that bind CD3 and tumor antigens
#28MULTIVALENT IgM- AND IgA-Fc-BASED BINDING MOLECULES
#29NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN
#30CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN AND ENCODING POLYNUCLEOTIDES
#31Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs
#32Methods of use of CD24 for the prevention and treatment of leukemia relapse
#33Heterodimeric proteins
#34Heterodimeric antibodies that bind CD3 and tumor antigens
#35Methods of treating neutorpenia using G-CSF protein complex
#36LONG ACTING PROTEIN COMPLEX HAVING AN ENHANCED EFFICIENCY
#37Fc-region variants with modified FcRn-binding and methods of use
#38Methods of use of soluble CD24 for treating immune related adverse events in cancer therapies
#39METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION
#40Heterodimerizing Ig domains
#41Method for selecting polypeptide producing cells
#42Protein complex by use of a specific site of an immunoglobulin fragment for linkage
#43C-terminal lysine conjugated immunoglobulins
#44Anti-MET antibodies and uses thereof
#45POLYPEPTIDE VARIANTS AND USES THEREOF
#46Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs
#47Immunoglobulin constant region Fc receptor binding agents
#48ANTIBODY CONSTANT REGION VARIANT
#49Heterodimeric antibodies that bind CD3 and tumor antigens
#50Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides
#51Antibodies for treatment and diagnosis of inflammatory bowel disease
#52Protein complex by use of a specific site of an immunoglobulin fragment for linkage
#53Heterodimeric antibodies that bind CD3 and tumor antigens
#54Non-human animals that select for light chain variable regions that bind antigen
#55Heterodimeric antibodies that bind CD3 and tumor antigens
#56Monoclonal antibodies against HER2
#57Monoclonal antibodies against HER2
#58Immunoglobulin constant region Fc receptor binding agents
#59MONOCLONAL ANTIBODIES AGAINST HER2
#60Long-acting insulin or insulin analogue conjugate
#61Heterodimeric proteins
#62Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use
#63Fc-region variants with modified FcRn-binding and methods of use
#64Immunoglobulin constant region Fc receptor binding agents
#65Multimeric Fc proteins
#66Heterodimeric antibodies to CD3 X CD123
#67Heterodimeric antibodies to CD3 X CD20
#68MULTIMERIC FC PROTEINS
#69Heterodimeric antibodies that bind CD3 and tumor antigens
#70Immunoglobulin constant region Fc receptor binding agents
#71NOVEL METHODS FOR THE STABILISATION OF IMMUNOGLOBULIN CONSTANT DOMAINS
#72Heterodimeric antibodies that bind CD3 and tumor antigens
#73Constant chain modified bispecific, penta- and hexavalent Ig-M antibodies
#74Monospecific polypeptide reagents
#75Antibody constant region variant
#76IgE CH3 peptide vaccine
#77Heterodimeric proteins
#78Heterodimeric proteins
#79Heterodimeric proteins
#80Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
#81Targeting of bone marrow neovasculature
#82Monoclonal antibodies against HER2
#83IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS
#84Monospecific polypeptide reagents
#85Targeting of bone marrow neovasculature
#86Antibody Constant Region Variant
#87IgE CH3 peptide vaccine
#88Protein-based assays for screening of the IgE-receptor interaction
#89Immunoglobulin constant region FC receptor binding agents